Skip to search formSkip to main contentSkip to account menu

ST2825

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Heterocyclic Compounds, 2-RingSpiro Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Disrupting myddosome assembly in diffuse large B-cell lymphoma cells using the MYD88 dimerization inhibitor ST2825
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkins lymphoma, is classified into germinal center and… 
Review
2018
Review
2018
TLR4-directed Molecular Strategies Targeting Skin Photodamage and Carcinogenesis.
BACKGROUND Exposure to solar ultraviolet (UV) radiation is a causative factor in skin photodamage and carcinogenesis, and… 
2018
2018
TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention
The present study investigated the mechanism underlying Toll-like receptor 4 (TLR4)-mediated stimulation of hypoxia-inducible… 
2017
2017
MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.
BACKGROUND/AIM Myeloid differentiation primary response gene 88 (MYD88), which activates the nuclear factor kappa B (NF-κB… 
2017
2017
Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats
Highly Cited
2016
Highly Cited
2016
Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
2016
2016
Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway.
Highly Cited
2015
Highly Cited
2015
Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70.
Highly Cited
2010
Highly Cited
2010
Pharmacologic Inhibition of Myeloid Differentiation Factor 88 (MyD88) Prevents Left Ventricular Dilation and Hypertrophy After Experimental Acute Myocardial Infarction in the Mouse
Background: Myeloid differentiation factor 88 (MyD88) is an endogenous adaptor protein that coordinates the inflammatory response… 
Highly Cited
2007
Highly Cited
2007
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
MyD88 is an adaptor protein, which plays an essential role in the intracellular signaling elicited by IL‐1R and several TLRs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License